Complement evasion mediated by enhancement of captured factor H: Implications for protection of self-surfaces from complement

Journal of Immunology

Volumn 195, Issue 10, 2015, Pages 4986-4998

  Herbert, Andrew P ^a   Makou, Elisavet ^a   Chen, Zhuo A ^a   Kerr, Heather ^a,b   Richards, Anna ^b   Rappsilber, Juri ^a   Barlow, Paul N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CD59 ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR; OSPC PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG; SPSA PROTEIN, STREPTOCOCCUS PNEUMONIAE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HEMOGLOBINURIA; HEMOLYSIS; HEMOLYSIS ASSAY; IMMUNE EVASION; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; STREPTOCOCCUS PNEUMONIAE; SURFACE PLASMON RESONANCE; CHEMISTRY; HUMAN; IMMUNOLOGY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PROTEIN TERTIARY STRUCTURE;

BACTERIAL PROTEINS; COMPLEMENT C3B; COMPLEMENT FACTOR H; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; PROTEIN STRUCTURE, TERTIARY; STREPTOCOCCUS PNEUMONIAE;

EID: 84958659965     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501388     Document Type: Article

References (54)

1. Ricklin, D., and J. D. Lambris. 2013. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J. Immunol. 190: 3831-3838.
2. Ricklin, D., and J. D. Lambris. 2013. Complement in immune and inflammatory disorders: therapeutic interventions. J. Immunol. 190: 3839-3847.
3. Lachmann, P. J. 2009. The amplification loop of the complement pathways. Adv. Immunol. 104: 115-149.
4. Schmidt, C. Q., A. P. Herbert, H. G. Hocking, D. Uhrín, and P. N. Barlow. 2008. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin. Exp. Immunol. 151: 14-24.
5. Ferreira, V. P., M. K. Pangburn, and C. Cortés. 2010. Complement control protein factor H: the good, the bad, and the inadequate. Mol. Immunol. 47: 2187-2197.
6. Perkins, S. J., R. Nan, K. Li, S. Khan, and A. Miller. 2012. Complement factor H-ligand interactions: self-association, multivalency and dissociation constants. Immunobiology 217: 281-297.
7. Makou, E., A. P. Herbert, and P. N. Barlow. 2013. Functional anatomy of complement factor H. Biochemistry 52: 3949-3962.
8. Ripoche, J., A. J. Day, T. J. Harris, and R. B. Sim. 1988. The complete amino acid sequence of human complement factor H. Biochem. J. 249: 593-602.
9. Soares, D. C., and P. N. Barlow. 2005. Complement control protein modules in the regulators of complement activation. In Structural Biology of the Complement System. D. Morikis, and J. D. Lambris, eds. CRC, Boca Raton, FL, p. 19-62.
10. de Córdoba, S. R., and E. G. de Jorge. 2008. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 151: 1-13.
11. Hageman, G. S., D. H. Anderson, L. V. Johnson, L. S. Hancox, A. J. Taiber, L. I. Hardisty, J. L. Hageman, H. A. Stockman, J. D. Borchardt, K. M. Gehrs, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102: 7227-7232.
12. Klein, R. J., C. Zeiss, E. Y. Chew, J. Y. Tsai, R. S. Sackler, C. Haynes, A. K. Henning, J. P. SanGiovanni, S. M. Mane, S. T. Mayne, et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
13. Edwards, A. O., R. Ritter, III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer. 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
14. Haines, J. L., M. A. Hauser, S. Schmidt, W. K. Scott, L. M. Olson, P. Gallins, K. L. Spencer, S. Y. Kwan, M. Noureddine, J. R. Gilbert, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
15. Blackmore, T. K., T. A. Sadlon, H. M. Ward, D. M. Lublin, and D. L. Gordon. 1996. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 157: 5422-5427.
16. Schmidt, C. Q., A. P. Herbert, D. Kavanagh, C. Gandy, C. J. Fenton, B. S. Blaum, M. Lyon, D. Uhrín, and P. N. Barlow. 2008. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 181: 2610-2619.
17. Clark, S. J., P. N. Bishop, and A. J. Day. 2010. Complement factor H and agerelated macular degeneration: the role of glycosaminoglycan recognition in disease pathology. Biochem. Soc. Trans. 38: 1342-1348.
18. Clark, S. J., L. A. Ridge, A. P. Herbert, S. Hakobyan, B. Mulloy, R. Lennon, R. Würzner, B. P. Morgan, D. Uhrín, P. N. Bishop, and A. J. Day. 2013. Tissuespecific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J. Immunol. 190: 2049-2057.
19. Richards, A., M. R. Buddles, R. L. Donne, B. S. Kaplan, E. Kirk, M. C. Venning, C. L. Tielemans, J. A. Goodship, and T. H. Goodship. 2001. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am. J. Hum. Genet. 68: 485-490.
20. Kavanagh, D., and T. Goodship. 2010. Genetics and complement in atypical HUS. Pediatr. Nephrol. 25: 2431-2442.
21. Gordon, D. L., R. M. Kaufman, T. K. Blackmore, J. Kwong, and D. M. Lublin. 1995. Identification of complement regulatory domains in human factor H. J. Immunol. 155: 348-356.
22. Appel, G. B., H. T. Cook, G. Hageman, J. C. Jennette, M. Kashgarian, M. Kirschfink, J. D. Lambris, L. Lanning, H. U. Lutz, S. Meri, et al. 2005. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J. Am. Soc. Nephrol. 16: 1392-1403.
23. Smith, R. J., J. Alexander, P. N. Barlow, M. Botto, T. L. Cassavant, H. T. Cook, S. R. de Córdoba, G. S. Hageman, T. S. Jokiranta, W. J. Kimberling, et al; Dense Deposit Disease Focus Group. 2007. New approaches to the treatment of dense deposit disease. J. Am. Soc. Nephrol. 18: 2447-2456.
24. Fridkis-Hareli, M., M. Storek, I. Mazsaroff, A. M. Risitano, A. S. Lundberg, C. J. Horvath, and V. M. Holers. 2011. Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. Blood 118: 4705-4713.
25. Schmidt, C. Q., H. Bai, Z. Lin, A. M. Risitano, P. N. Barlow, D. Ricklin, and J. D. Lambris. 2013. Rational engineering of a minimized immune inhibitor with unique triple-targeting properties. J. Immunol. 190: 5712-5721.
26. Hebecker, M., M. Alba-Domínguez, L. T. Roumenina, S. Reuter, S. Hyvärinen, M. A. Dragon-Durey, T. S. Jokiranta, P. Sánchez-Corral, and M. Józsi. 2013. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H. J. Immunol. 191: 912-921.
27. Brodsky, R. A. 2014. Paroxysmal nocturnal hemoglobinuria. Blood 124: 2804-2811.
28. Zipfel, P. F., C. Skerka, J. Hellwage, S. T. Jokiranta, S. Meri, V. Brade, P. Kraiczy, M. Noris, and G. Remuzzi. 2002. Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 30: 971-978.
29. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6: 132-142.
30. Blom, A. M., T. Hallström, and K. Riesbeck. 2009. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol. Immunol. 46: 2808-2817.
31. Janulczyk, R., F. Iannelli, A. G. Sjoholm, G. Pozzi, and L. Bjorck. 2000. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J. Biol. Chem. 275: 37257-37263.
32. Dave, S., A. Brooks-Walter, M. K. Pangburn, and L. S. McDaniel. 2001. PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69: 3435-3437.
33. Jarva, H., R. Janulczyk, J. Hellwage, P. F. Zipfel, L. Björck, and S. Meri. 2002. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J. Immunol. 168: 1886-1894.
34. Hyams, C., K. Trzcinski, E. Camberlein, D. M. Weinberger, S. Chimalapati, M. Noursadeghi, M. Lipsitch, and J. S. Brown. 2013. Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b. Infect. Immun. 81: 354-363.
35. Schmidt, C. Q., F. C. Slingsby, A. Richards, and P. N. Barlow. 2011. Production of biologically active complement factor H in therapeutically useful quantities. Protein Expr. Purif. 76: 254-263.
36. Nan, R., J. Gor, I. Lengyel, and S. J. Perkins. 2008. Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease. J. Mol. Biol. 384: 1341-1352.
37. Wu, J., Y. Q. Wu, D. Ricklin, B. J. Janssen, J. D. Lambris, and P. Gros. 2009. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10: 728-733.
38. Pangburn, M. K. 2002. Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J. Immunol. 169: 4702-4706.
39. Ezzell, J. L., L. A. Wilcox, N. J. Bernshaw, and C. J. Parker. 1991. Induction of the paroxysmal nocturnal hemoglobinuria phenotype in normal human erythrocytes: effects of 2-aminoethylisothiouronium bromide on membrane proteins that regulate complement. Blood 77: 2764-2773.
40. Schuck, P. 2000. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78: 1606-1619.
41. Vranken, W. F., W. Boucher, T. J. Stevens, R. H. Fogh, A. Pajon, M. Llinas, E. L. Ulrich, J. L. Markley, J. Ionides, and E. D. Laue. 2005. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59: 687-696.
42. Chen, Z. A., A. Jawhari, L. Fischer, C. Buchen, S. Tahir, T. Kamenski, M. Rasmussen, L. Lariviere, J. C. Bukowski-Wills, M. Nilges, et al. 2010. Architecture of the RNA polymerase II-TFIIF complex revealed by cross-linking and mass spectrometry. EMBO J. 29: 717-726.
43. Ishihama, Y., J. Rappsilber, and M. Mann. 2006. Modular stop and go extraction tips with stacked disks for parallel and multidimensional Peptide fractionation in proteomics. J. Proteome Res. 5: 988-994.
44. Dave, S., M. K. Pangburn, C. Pruitt, and L. S. McDaniel. 2004. Interaction of human factor H with PspC of Streptococcus pneumoniae. Indian J. Med. Res. 119(Suppl.): 66-73.
45. Hammerschmidt, S., V. Agarwal, A. Kunert, S. Haelbich, C. Skerka, and P. F. Zipfel. 2007. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J. Immunol. 178: 5848-5858.
46. Lu, L., Y. Ma, and J. R. Zhang. 2006. Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J. Biol. Chem. 281: 15464-15474.
47. Duthy, T. G., R. J. Ormsby, E. Giannakis, A. D. Ogunniyi, U. H. Stroeher, J. C. Paton, and D. L. Gordon. 2002. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infect. Immun. 70: 5604-5611.
48. Achila, D., A. Liu, R. Banerjee, Y. Li, E. Martinez-Hackert, J. R. Zhang, and H. Yan. 2015. Structural determinants of host specificity of complement Factor H recruitment by Streptococcus pneumoniae. Biochem. J. 465: 325-335.
49. Morgan, H. P., C. Q. Schmidt, M. Guariento, B. S. Blaum, D. Gillespie, A. P. Herbert, D. Kavanagh, H. D. Mertens, D. I. Svergun, C. M. Johansson, et al. 2011. Structural basis for engagement by complement factor H of C3b on a self surface. Nat. Struct. Mol. Biol. 18: 463-470.
50. Kazatchkine, M. D., D. T. Fearon, and K. F. Austen. 1979. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and b1 H for cell-bound C3b. J. Immunol. 122: 75-81.
51. Pangburn, M. K., N. Rawal, C. Cortes, M. N. Alam, V. P. Ferreira, and M. A. Atkinson. 2009. Polyanion-induced self-association of complement factor H. J. Immunol. 182: 1061-1068.
52. Goicoechea de Jorge, E., J. J. Caesar, T. H. Malik, M. Patel, M. Colledge, S. Johnson, S. Hakobyan, B. P. Morgan, C. L. Harris, M. C. Pickering, and S. M. Lea. 2013. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. USA 110: 4685-4690.
53. Weismann, D., K. Hartvigsen, N. Lauer, K. L. Bennett, H. P. Scholl, P. Charbel Issa, M. Cano, H. Brandstätter, S. Tsimikas, C. Skerka, et al. 2011. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478: 76-81.
54. Krissinel, E., and K. Henrick. 2007. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372: 774-797.